Probing interaction requirements in PTP1B inhibitors: a comparative molecular dynamics study

Area of Science:

• Biochemistry
• Structural Biology
• Computational Chemistry

Background:

• Protein tyrosine phosphatase 1B (PTP1B) is a key regulator of cellular signaling pathways.
• Dysregulation of PTP1B activity is implicated in metabolic diseases like diabetes and obesity.
• Targeting PTP1B with small molecules is a promising therapeutic strategy.

Purpose of the Study:

• To investigate the molecular interactions and energy components governing substrate and inhibitor binding to PTP1B.
• To identify structural features crucial for PTP1B inhibition.
• To provide insights for the rational design of novel PTP1B inhibitors.

Main Methods:

• Molecular dynamics (MD) simulations were conducted on eight distinct PTP1B crystal structure complexes.
• Binding free energies were calculated using molecular mechanics-Poisson-Boltzmann surface area (MM/PBSA) and generalized Born surface area (MM/GBSA) methods.
• Free energy decomposition and hydrogen-bond analysis were performed to assess individual contributions.

Main Results:

• MD studies revealed rigidity in the WPD loop, a critical feature for PTP1B inhibition.
• Analysis of energy components highlighted the importance of electrostatic and van der Waals interactions for ligand binding.
• Both active site and allosteric inhibitors showed significant contributions from van der Waals forces.

Conclusions:

• A balanced interplay between electrostatic and van der Waals interactions is essential for designing effective active site inhibitors.
• Van der Waals interactions play a significant role, alongside electrostatic forces, in the binding affinity of allosteric inhibitors.
• The findings provide a molecular basis for developing targeted PTP1B inhibitors for therapeutic applications.